Skip to content

Roxanne Sholevar

5 papers in the library · 27 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy

BMJ Supportive & Palliative Care November 3, 2025 Yvan Beaussant, Zachary Sager, Caitlin W. Brennan et al. 1 citation

Objectives To assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy (PAT) for demoralisation in terminally ill patients receiving home hospice care. Methods In this open-label pilot trial, 4607 home hospice patients at a large community hospice were screened over 22 months; 66 were approached, 15 enrolled and 10 received psilocybin. Participants completed two...

Ketamine and Ketamine-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Serious Medical Illness: A Narrative Review.

Journal of Palliative Medicine January 22, 2025 Roxanne Sholevar, William Kromka, Yvan Beaussant 10 citations

Context: Psychiatric and existential distress are common and difficult-to-treat symptoms that are frequently encountered in the palliative care setting; current treatment options are limited in efficacy and tolerability. Psychedelic-assisted therapies (PAT) have gained public and scientific interest in their potential to induce rapid and effective reductions in psychiatric and existential...

Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.

General Hospital Psychiatry 2025 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam et al. 3 citations

Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited. This study explores factors influencing the acceptability of PAT...

Disruption as an opportunity or threat: A qualitative analysis of factors influencing the attitudes of experts in serious illness care toward psychedelic-assisted therapies.

Palliative & Supportive Care December 1, 2023 Roxanne Sholevar, John Peteet, Justin J. Sanders et al. 9 citations

Psychedelic-assisted therapies (PAT) are emerging as a promising treatment for psycho-existential distress in patients with serious illness. A recent qualitative analysis of perspectives of 17 experts in serious illness care and/or PAT research identified divergent views on the therapeutic potential and safety of PAT in patients with serious illness. This paper further analyzes the factors that...

Psychedelic-Assisted Therapies in Patients With Serious Illness: Opportunities and Challenges

Psychiatric Annals September 1, 2022 Michael Ljuslin, Kabir Nigam, Roxanne Sholevar et al. 4 citations

In addition to physical symptoms and treatment burden, people affected by serious illness experience psychological, social, and spiritual distress. Medical professionals who care for them, including psychiatrists and other mental health clinicians, attend to these multiple dimensions of suffering with the hope and promise of improving patients' quality of life. Yet anxiety, depression,...